Ironwood Financial’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-9
| Closed | -$1K | – | 593 |
|
|
2021
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 557 |
|
|
2021
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 545 |
|
|
2021
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 528 |
|
|
2020
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 508 |
|
|
2020
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 426 |
|
|
2020
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 397 |
|
|
2020
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 341 |
|
|
2019
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 370 |
|
|
2019
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 375 |
|
|
2019
Q2 | $3K | Hold |
9
| – | – | ﹤0.01% | 341 |
|
|
2019
Q1 | $4K | Hold |
9
| – | – | ﹤0.01% | 324 |
|
|
2018
Q4 | $4K | Hold |
9
| – | – | ﹤0.01% | 318 |
|
|
2018
Q3 | $8K | Sell |
9
-7
| -44% | -$6.22K | ﹤0.01% | 275 |
|
|
2018
Q2 | $9K | Buy |
16
+8
| +100% | +$4.5K | 0.01% | 198 |
|
|
2018
Q1 | $5K | Hold |
8
| – | – | 0.01% | 211 |
|
|
2017
Q4 | $3K | Hold |
8
| – | – | ﹤0.01% | 227 |
|
|
2017
Q3 | $3K | Hold |
8
| – | – | ﹤0.01% | 236 |
|
|
2017
Q2 | $4K | Hold |
8
| – | – | ﹤0.01% | 224 |
|
|
2017
Q1 | $10K | Sell |
8
-7
| -47% | -$8.75K | 0.01% | 173 |
|
|
2016
Q4 | $6K | Buy |
15
+10
| +200% | +$4K | ﹤0.01% | 201 |
|
|
2016
Q3 | $2K | Hold |
5
| – | – | ﹤0.01% | 251 |
|
|
2016
Q2 | $2K | Hold |
5
| – | – | ﹤0.01% | 255 |
|
|
2016
Q1 | $2K | Buy |
+5
| New | +$2K | ﹤0.01% | 259 |
|
|
2015
Q3 | $7K | Buy |
5
+3
| +150% | +$4.2K | ﹤0.01% | 238 |
|
|
2015
Q2 | $3K | Buy |
+2
| New | +$3K | ﹤0.01% | 285 |
|